Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats

详细信息    查看全文

• 作者：Jessica M. Carpenter^a ; Catherine A. Criddle^b ; Helaina K. Craig^a ; Zulfiqar Ali^a ; Zhihao Zhang^a ; Ikhlas A. Khan^a ; Kenneth J. Sufka^a ; ^b ; ^{pysufka@olemiss.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Mitragyna speciosa (Korth.) Havil. ; Mitragynine ; Hotplate ; Opioids ; Oral ; Intraperitoneal
• 刊名：Fitoterapia
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：109
• 期：Complete
• 页码：87-90
• 全文大小：302 K

文摘

This study sought to compare the effects of Mitragyna speciosa (Korth.) Havil. extract, alkaloids fraction, and mitragynine, a μ-opioid receptor agonist, to that of morphine and oxycodone in a test of thermal nociception. In Experiment 1, male Sprague–Dawley rats were administered test articles intraperitoneally (IP) 30 min prior to testing to compare the effects of M. speciosa articles to opioid reference compounds on the hotplate assay. Test articles were vehicle, 10 mg/kg morphine, 3 mg/kg oxycodone, 300 mg/kg M. speciosa extract, 75 mg/kg M. speciosa alkaloids fraction, or 30 mg/kg mitragynine. To mirror consumer usage, Experiment 2 sought to determine whether M. speciosa articles retained their biological activity when given orally (PO). Test articles were vehicle, 6 mg/kg oxycodone, 300 mg/kg M. speciosa extract, or 100 mg/kg mitragynine with hotplate tests conducted 30 and 60 min after administration. Mitragynine produced antinociceptive effects similar to the reference opioid agonists when administered IP and PO routes. These data suggest that M. speciosa extracts containing significant quantities of mitragynine may warrant consideration for further studies in primate self-administration models to yield insight into the abuse liability of this commercially available product.